Question 1

What is Monopar Therapeutics's accounts payable?

Accepted Answer

Monopar Therapeutics (MNPR) reported accounts payable of $2.46M in Q1 2026.

Question 2

How has Monopar Therapeutics's accounts payable changed year-over-year?

Accepted Answer

Monopar Therapeutics's accounts payable increased by 64.7% year-over-year, from $1.49M to $2.46M.

Question 3

What is the long-term trend for Monopar Therapeutics's accounts payable?

Accepted Answer

Over 5 years (2020 to 2025), Monopar Therapeutics's accounts payable has grown at a 18.4% compound annual growth rate (CAGR), from $1.18M to $2.74M.

Question 4

What does accounts payable mean?

Accepted Answer

Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.

Line item	March 31, 2026	December 31, 2025*
Total assets	$137,983,725	$140,717,709
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable, accrued expenses and other current liabilities	$2,457,748	$2,735,236
Total current liabilities	2,457,748	2,735,236
Non-current operating lease liability	131,565	154,920
Total liabilities	2,589,313	2,890,156
Commitments and contingencies (Note 8)

Accounts Payable at other companies

Other financials